The purpose of this study is to evaluate standard of care exercise education alone or in combination with a wearable physical activity tracker in people with epilepsy (PWE) to determine the most effective way to increase physical activity and measure impact on depression, anxiety, quality of life, sleep, and seizure frequency.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
80
In addition to the standard of care exercise education, participants in the activity tracker group will be provided a Fitbit physical activity tracker at no cost to the participants. They will be asked to download the Fitbit application (app) to their personal smartphone device to allow them to see their own data collected by the Fitbit. They will also be asked to download the Stridekick app for the purpose of sharing their activity tracker data electronically with the study team and having the opportunity to participate in fitness challenges through the app. App accounts will be created by the participants with usernames that do not contain the participant's identifiable personal information. Optional fitness challenges will be created once per month by the study investigators, and participants will also receive a weekly message of encouragement from the study team.
Participants will receive standard of care exercise education.
The University of Texas Health Science Center at Houston
Houston, Texas, United States
Number of steps taken by participant
Time frame: 3 months after enrollment
Total distance traveled by participant
Time frame: 3 months after enrollment
Total time participant is active
measured in minutes
Time frame: 3 months after enrollment
Depression as measured by the Patient Health Questionnaire depression scale (PHQ-9)
this is scored form 0-27 with a higher number indicating higher severity
Time frame: Baseline
Depression as measured by the Patient Health Questionnaire depression scale (PHQ-9)
this is scored form 0-27 with a higher number indicating higher severity
Time frame: end of study (3 months after enrollment)
Anxiety as measured by the General Anxiety Disorder 7-item scale (GAD-7)
The GAD-7 score ranges form 0 (minimal anxiety) to 21 (severe anxiety)
Time frame: Baseline
Anxiety as measured by the General Anxiety Disorder 7-item scale (GAD-7)
The GAD-7 score ranges form 0 (minimal anxiety) to 21 (severe anxiety)
Time frame: end of study (3 months after enrollment)
Sleep as measures by the Epworth Sleepiness Scale (ESS)
The ESS scale ranges form 0 (would never dose) to 3 (high chance of dozing)
Time frame: Baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Sleep as measures by the Epworth Sleepiness Scale (ESS)
The ESS scale ranges form 0 (would never dose) to 3 (high chance of dozing)
Time frame: end of study (3 months after enrollment)
Quality of life as assessed by the Quality of Life in Epilepsy (QOLIE-10-P) survey
The range of total scores for the QOLIE-10-P survey is 1 to 5, with 1 indicating a better outcome.
Time frame: Baseline
Quality of life as assessed by the Quality of Life in Epilepsy (QOLIE-10-P) survey
The range of total scores for the QOLIE-10-P survey is 1 to 5, with 1 indicating a better outcome.
Time frame: end of study (3 months after enrollment)